Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098614 · ClinicalTrials.gov registry record · NA
Barriers to Substance Use Disorder Recovery
A NA study of Substance Use Disorders, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT04098614: Completed NA study of Substance Use Disorders, sponsored by Prisma Health-Upstate.
NCT04098614 is a NA study of Substance Use Disorders that has completed, run by Prisma Health-Upstate. The registered enrollment target is 99 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04098614, a NA study of Substance Use Disorders, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
The study purpose is to investigate how an inpatient recovery coaching intervention can overcome or mitigate specific risk factors and barriers to initiating and maintaining Substance Use Disorder recovery. This study will offer insight into how and why an inpatient link to recovery coaching is effective for promoting long-term Substance Use Disorder recovery.
Primary Outcome
Participants will complete the 5-item Social Support subscale of the Assessment of Recovery Capital (ARC) to assess social support. The difference between the post-baseline and baseline measures will be assessed.
Conditions Studied
Interventions
- BEHAVIORAL Recovery Coach Intervention
Study Locations (1)
South Carolina
- Greenville Memorial Hospital - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2020-12-18 |
| Phase | NA |
What the finished NCT04098614 record still lists
NCT04098614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Recovery Coach Intervention is the first listed.
NCT04098614 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT04098614 about?
NCT04098614 is a clinical study titled "Barriers to Substance Use Disorder Recovery". The study purpose is to investigate how an inpatient recovery coaching intervention can overcome or mitigate specific risk factors and barriers to initiating and maintaining Substance Use Disorder recovery. This study will offer insight into how and why an inpatient link to recovery coaching is effe...
What is the current status of trial NCT04098614?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2019-09-03. Estimated completion is 2020-12-18.
What conditions does trial NCT04098614 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT04098614?
The interventions under investigation include: Recovery Coach Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04098614?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04098614 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04098614's enrollment target sits among peer trials
99 53rd of 93 higher than 41 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI